Topic Archives: Ligand Pharmaceuticals (LGND)

I’ve only written once about the Smallcap Discoveries service, so when several readers sent in questions about its “what if you could live to 200?” pitch, I decided to dig in a little. Longevity is a frequent focus of the alternative health crowd, promising life extension to those most obviously interested in the topic (who […]

We’ve seen a long stream of earnings reports and other worthwhile bits of data on Real Money Portfolio stocks since I last wrote to you, including some that actually included some interesting news, so prepare for a lot of quick updates…. Medical Properties Trust (MPW) reported another quarter of ho-hum… pretty much met the forecasts, […]

Each year I go through all of the stocks that I either own personally or have brought to the attention of the Irregulars (there’s quite a bit of overlap on those lists), and I make sure to update my thoughts and opinion on that stock in an organized and, hopefully, disciplined way — that helps […]

All of you, dear Irregulars, know that Stock Gumshoe is not a “tip sheet,” and I don’t operate a portfolio for other people to emulate or copy, or even attempt to track the stocks we cover as if they were a portfolio of buys and sells with consistent trading advice… but I do keep a […]

Just a quick note that GlaxoSmithKline released results yesterday — for those who are interested in Ligand, which I own and have written about several times over the past year, the Promacta news looked pretty good. Despite Lemelson’s short argument that Promacta is a rapidly declining and worthless drug because of better Hepatitis C treatment […]

Just FYI, I noticed that while I was on the road a limit buy order triggered for my account that I didn’t have the chance to write to you about yesterday — I bought another slug of Ligand Pharmaceuticals (LGND) at $42.50, so I’ve increased my holdings in that stock by about 50%. Now a […]

Comments

  • Avatar

    Since his buying advice the stock dropped 50%,you better short the stocks he recs ,never pay hundreds or thousends $ for...

  • Avatar

    Travis, Does LGND have to follow the royalty model? SAND turned its fortunes when it broke the mold. Perhaps LGND is go...

  • Avatar

    Travis, Does tonight's news from LGND change the assessment you made when closing position? My quick take is that expec...

  • Travis Johnson, Stock Gumshoe

    Ligand Pharmaceuticals (LGND) announced a bombshell today, they're selling Promacta to Novartis and Royalty Pharma for $...

  • Avatar

    Based upon other posts, it's Ligand Pharmaceuticals (LGND). They're down more than 50%...

  • Avatar

    Thank you Travis. Yes, I noticed LGND went down 50% in the past couple months. It's either a bad sign of things to come ...

  • Avatar

    Bought into LGND on Christmas Eve, and if it wasn't for occasionally reading about your strategies including stop losses...

  • Avatar

    Travis: Kudos for selling part of the position when things looked good and for sticking to stop loss discipline for the ...

  • Travis Johnson, Stock Gumshoe

    I watch stop losses for all my stocks, but don't follow them mechanically -- I take them far more seriously for momentum...

  • Travis Johnson, Stock Gumshoe

    The lawsuits like that will crop up everywhere, though probably won’t mean anything — that’s just lawyers trying t...

  • Travis Johnson, Stock Gumshoe

    I had a stop loss order in for Ligand as sort of a "disaster" price if the narrative really falls apart, given my assess...

  • Travis Johnson, Stock Gumshoe

    Just ran into this comment when looking for some info about Ligand that I had written -- not trying to pick on the Doc, ...

  • Travis Johnson, Stock Gumshoe

    Haven't written about Lichtenfeld's tease, but someone sent it to me today and it's clearly Ligand being touted as this ...

  • DrKSSMDPhD

    Dan: I am a little rattled because I had been intending to present Madrigal as a long idea of the month for December, an...

  • DrKSSMDPhD

    Dova Pharmaceuticals will be debuting by IPO shortly, and this one's interesting. It's a play on avatrombopag, a second-...

  • Avatar

    ddman92129, In my humble opinion if you simply must be in biotech, buy with the money you can afford to lose $IBB and ...

  • Avatar

    I took the "Bait" and subscribed to Riggs' "Small Cap Rocket" newsletter, but only because it came with a grantee that i...

  • Travis Johnson, Stock Gumshoe

    Not 8 stocks, 8 drugs. As to whether it's LGND, there's no room for doubt given those clues: either he's recommending L...

  • Avatar

    Thanks for this. So, knowing the names of the 8 stocks themselves doesn't really matter. Now is there anyone who did j...

  • Avatar

    LGND for almost 8 points so far from 115 to 123 although it has basically just beat the IBB by a few percent....

  • SoGiAm

    $LGND also covered in this February article: http://www.stockgumshoe.com/2016/02/february-idea-of-the-month/ Best2You-...

  • Avatar

    Travis, I can't remember what you ended up doing with $LGND, but noticed it is now up to around 100 again. Remember a ...

  • Avatar

    Dang Travis. Have you seen Ligand $LGND lately? Doubled since Feb. They report earnings for 2Q after market closes today...

  • Avatar

    Thanks Travis, When I see a lousy looking chart and large short interest it reminds me of LGND and look what that chart...

  • Travis Johnson, Stock Gumshoe

    I mean that if results are better than expected and the stock rises, there are enough short sellers that it's possible t...

  • Travis Johnson, Stock Gumshoe
  • Travis Johnson, Stock Gumshoe

    The last time I wrote about Ligand, following that short analysis, was here: http://www.stockgumshoe.com/2014/06/points-...

  • Avatar

    Travis, What do you make of this firm's analysis of Ligand? See below. http://www.valuewalk.com/2014/06/lemelson-lig...

  • Avatar

    Dr. KSS; I wonder if you have any comment on LGND. It is a stock that Travis and I own, as likely others, which took a ...

  • Avatar

    Robert- you are correct on SVA. Dead money for months now and will likely go lower in the near future. LGND on the other...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info